(Q92187919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

title

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

27 April 2020

main subject

doxorubicin

0 references

corrigendum / erratum

0 references

author name string

Xu Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Renjie Hui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Yun Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Wentao Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Yujiao Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Xiaohai Gong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jian Jin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

publication date

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Pharmacology

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

1434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

27 April 2020

copyright license

start time

6 December 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Identification of Human UMP/CMP Kinase 1 as Doxorubicin Binding Target Using Protein Microarray

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Limitations in doxorubicin production from Streptomyces peucetius

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

New developments in anthracycline-induced cardiotoxicity.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Cellular mechanisms of multidrug resistance of tumor cells.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Reactions of adriamycin with microsomal iron and lipids

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909010

23 February 2021

Identifiers

DOI

10.3389/FPHAR.2019.01434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31866863%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference